Paul Perreault, CSL Seqirus CEO
CSL Seqirus snaps up $30M+ BARDA contract to develop influenza vaccine at its expanded facility in NC
Only a few months after expanding its facility in Holly Springs, NC, vaccine maker CSL Seqirus is putting the new location to use with its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
